Modified histologic grading of neuroblastomas by replacement of mitotic rate with Mitosis Karyorrhexis Index: A clinicopathologic study of 223 cases from the Pediatric Oncology Group

Cancer

Volumn 77, Issue 8, 1996, Pages 1582-1588

  Joshi, Vijay V ^a,e   Rao, Pejaver V ^b   Cantor, Alan B ^b   Altshuler, Geoff ^c   Shuster, Jon J ^b   Castleberry, Robert P ^d  

^a EAST CAROLINA UNIVERSITY   (United States)

^b Pediat Oncol Grp Stat Office   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e Operations Office   (United States)

Author keywords

histologic grading; Mitosis Karyorrhexis Index; neuroblastoma; prognosis

Indexed keywords

ARTICLE; CALCIFICATION; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; CHILD; HUMAN; MAJOR CLINICAL STUDY; MITOSIS RATE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS;

CHILD; FOLLOW-UP STUDIES; HUMANS; INFANT; MITOTIC INDEX; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0029866213     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1582::AID-CNCR24>3.0.CO;2-V     Document Type: Article

References (14)

1. Joshi VV, Cantor AB, Altshuler A, Larkin EW, Neill JSA, Shuster JJ, et al. Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas: a clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 1992;69:2197-211.
2. Joshi W, Cantor AB, Brodeur GM, Look AT, Shuster JJ, Altshuler G, et al. Correlation between morphologic and other prognostic markers of neuroblastoma: a study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group. Cancer 1993;71:3173-81.
3. Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16.
4. Joshi W, Chatten J, Sather HN, Shimada H. Evaluation of Shimada classification in advanced neuroblastoma with a special reference to the mitosis karyorrhexis index: a report from the Children's Cancer Study Group. Modern Pathol 1991;4:139-47.
5. Shimada H, Stram DO, Chatten J, Ioshi VV, Hachitanda Y, Brodeur G, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995;87:1470-76.
6. Joshi V, Altshuler G, Cantor A, Larkin E, Neill I, Shuster J, et al. Modification of Shimada terminology and Shimada classification (SC) in 213 cases of neuroblastic tumors (NTs) from Pediatric Oncology Group (POG). Modern Pathol 1991;4:109A.
7. Enzinger FM, Weiss SW. Soft tissue tumors. St. Louis: C.V. Mosby, 1983;657-75.
8. Beckwith JB. Wilms' tumor and other renal tumors in children. Human Pathol 1983;14:481-92.
9. Peto R, Pike MC, Armitage P, Breslow NE, Cere DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. Analysis and examples. Br J Cancer 1977;35:1-39.
10. Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA contents as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984;311:231-5.
11. Wenzel A, Cziepluch C, Hamann V, Schurmann J, Schwab M. The N-myc oncoprotein is associated in vivo with the phosphoprotein Max (p 20/22) in human neuroblastoma cells. EMBO J 1991;10:3703-12.
12. Kato GJ, Dang CV. Function of the c-myc oncoprotein. FASEB J 1992;6:3065-72.
13. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-28.
14. Chatten J, Shimada H, Sather HN, Wong KW, Siegel SE, Hammond AD. Prognostic value of histopathology in advanced neuroblastoma: a report from Children's Cancer Study Group. Human Pathol 1988;19:1187-98.